Lung cancer is still one of the most common malignancies with a high global mortality rate with over 2 million cases confirmed by the World Health Organization in 2018. Although there has been ...

The following is a summary of “Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies,” published in the December 2024 issue of Hematology by Hersby et al. Large B-cell ...

Lung cancer was nowhere on her radar. "We're definitely seeing more and more, not only lung cancer, but really all cancers in ...

Lung cancer is one of the most common, most dangerous, and most frequently talked about forms of cancer in the world. Of all ...

A mathematical model shows that mutations that recur even modestly among cancer patients are cancer driving nucleotides that can be exhaustively identified to serve as targets of cancer therapy.

The following is a summary of “Research Trends of Artificial Intelligence in Lung Cancer: A Combined Approach of Analysis ...

Antibody-drug conjugates (ADCs) represent a promising cancer treatment modality designed to deliver highly potent cytotoxic ...

Essentially, what Concr demonstrates is that training their algorithms on smaller, yet more diverse, data can lead to increased accuracy, due to the broader biological variability within that training ...

Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening.

The global cancer biopsy market is set to experience robust growth, with a market size of USD 25.5 billion in 2023, according ...

Sabari, MD, which focused on the approval of amivantamab plus lazertinib in the first line, he looks ahead to potential uses ...